WallStreetZenWallStreetZen

NASDAQ: IKT
Inhibikase Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Should I buy or sell IKT stock?

Based on 1 analyst offering ratings for Inhibikase Therapeutics Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IKT stock forecasts and price targets.

IKT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
JonesTrading
Bottom 10%
10
HoldDowngradesN/AN/A2022-11-16

1 of 1

IKT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IKT$0.66N/AN/AHold
AGLE$0.29$1.50+417.24%Buy
SABS$0.44$4.00+809.09%Buy
FNCH$0.39N/AN/A
CYCN$0.43N/AN/A
View Top Biotech Stocks

Inhibikase Therapeutics Stock Forecast FAQ

Is Inhibikase Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: IKT) stock is to Hold IKT stock.

Out of 1 analyst, 0 (0%) are recommending IKT as a Strong Buy, 0 (0%) are recommending IKT as a Buy, 1 (100%) are recommending IKT as a Hold, 0 (0%) are recommending IKT as a Sell, and 0 (0%) are recommending IKT as a Strong Sell.

If you're new to stock investing, here's how to buy Inhibikase Therapeutics stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.